L. Mary Smith
7Patents
5h-index
5Co-inventors
52Inventor score
Filing activity: Mar 27, 2006 → Jun 28, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7812135B2 | GITR-binding antibodies | Emerging Cross-Sectional Technologies | 121 | Expired |
| US8388967B2 | Methods for inducing or enhancing an immune response by administering agonistic GITR-binding antibodies | Emerging Cross-Sectional Technologies | 101 | Active |
| US9028823B2 | Methods of inducing or enhancing an immune response in a subject by administering agonistic GITR binding antibodies | Emerging Cross-Sectional Technologies | 22 | Active |
| US8901281B2 | ILT3 binding molecules and uses therefor | Chemistry; Metallurgy | 10 | Active |
| US9493572B2 | GITR antibodies and methods of inducing or enhancing an immune response | Emerging Cross-Sectional Technologies | 6 | Active |
| US10030074B2 | Methods of inducing or enhancing an immune response in a subject having cancer by administering GITR antibodies | Emerging Cross-Sectional Technologies | 1 | Active |
| US10570209B2 | Methods for inducing or enhancing an immune response by administering agonistic glucocorticoid-induced TNFR-family-related receptor (GITR) antibodies | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.